SCHEMBL7564949

SCHEMBL7564949

COc1ccc2nc3c(C(=O)O)cccc3nc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
POLB P06746 6/20 0.63
KMT2A Q03164 5/20 0.63
RAB9A P51151 4/20 0.63
MEN1 O00255 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
MAPT P10636 2/20 0.63
THRB P10828 1/20 0.63
BLM P54132 1/20 0.63
CASP6 P55212 1/20 0.63
KDM4E B2RXH2 7/20 0.59
LMNA P02545 3/20 0.59
NPC1 O15118 3/20 0.59
NQO2 P16083 3/20 0.59
HPGD P15428 2/20 0.51
HSD17B10 Q99714 1/20 0.51
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573459 1.00 ALDH1A1 (0.65) ALDH1A1POLBKMT2ARAB9AMEN1
SCHEMBL5886295 0.85 KDM4E (0.54) ALDH1A1POLBKMT2ARAB9AMEN1
SCHEMBL5886371 0.84 KDM4E (0.52) ALDH1A1POLBKMT2ARAB9AMEN1
SCHEMBL7570741 0.81 ALDH1A1 (0.71) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL2288888 0.81 ALDH1A1 (0.71) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL7568147 0.81 KDM4E (0.48) ALDH1A1POLBKMT2ARAB9AMEN1
SCHEMBL7566734 0.81 KDM4E (0.51) ALDH1A1POLBKMT2ARAB9AMEN1
Phenazine-1-Carboxylic Acid SCHEMBL27752237 0.80 ALDH1A1 (0.93) ALDH1A1KMT2ARAB9AMEN1SMN1; SMN2
Phenazine-1-Carboxylic Acid SCHEMBL122864 0.80 ALDH1A1 (1.00) ALDH1A1KMT2ARAB9AMEN1SMN1; SMN2
Phenazine-1-Carboxylic Acid SCHEMBL27884214 0.80 ALDH1A1 (1.00) ALDH1A1KMT2ARAB9AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856225-B2 Substituted phenazines as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2018-01-02 US disclosed
US-20160355487-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2016-12-08 US disclosed
US-20160355487-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2016-12-08 US disclosed
EP-3086791-A2 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS University of Florida Research Foundation, Inc. (US) 2016-11-02 EP disclosed
WO-2015100331-A2 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-07-02 WO disclosed
WO-2015100331-A2 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-07-02 WO disclosed
EP-0934278-B1 BIS(ACRIDINECARBOXAMIDE) AND BIS(PHENAZINECARBOXAMIDE) AS ANTITUMOUR AGENTS XENOVA LTD (GB) 2002-09-04 EP disclosed
US-6114332-A BACTERICIDES XENOVA LIMITED (GB) 2000-09-05 US disclosed
EP-0934278-A1 BIS(ACRIDINECARBOXAMIDE) AND BIS(PHENAZINECARBOXAMIDE) AS ANTITUMOUR AGENTS XENOVA LIMITED (GB) 1999-08-11 EP disclosed
WO-1998017650-A1 BIS(ACRIDINECARBOXAMIDE) AND BIS(PHENAZINECARBOXAMIDE) AS ANTITUMOUR AGENTS XENOVA LIMITED (GB) 1998-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160355487-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS ROS1, NOX4, NOX5 ALDH1A1 1136/4885POLB 938/4885KMT2A 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.